Literature DB >> 21091879

Circulating sex hormones play no role in the association between sexual activity and the risk of prostate cancer.

Hamed Ahmadi1, Farzad Allameh, Nima Baradaran, Laleh Montaser-Kouhsari, Shahrzad Bazargan-Hejazi, Sepehr Salem, Abdolrasoul Mehrsai, Gholamreza Pourmand.   

Abstract

INTRODUCTION: High sexual activity (SA) has been reported to reduce the risk of prostate cancer (PC). The role of sex hormones (SHs) in this regard remains controversial. AIMS: To determine the impact of SA and SHs on PC development.
METHODS: In a multicentric hospital-based case-control study, 194 newly diagnosed PC patients along with 317 age-matched controls were studied. Sociodemographic and medical characteristics of participants were recorded. History of vasectomy and sexually transmitted infection (STI), marital status, age at first intercourse, premarital sex, and the current frequency of sexual intercourses per month (SPM) were evaluated. Total testosterone (TT), free testosterone (FT), estradiol (ES), sex hormone binding globulin, and albumin were also measured. Logistic regression model was used to identify independent risk factors for PC. MAIN OUTCOME MEASURES: (i) The association between SA, SHs, and the risk of PC; (ii) The correlation between SHs and SA; (iii) The interaction between SHs and SA and established risk factors for PC and erectile dysfunction in determining the risk of PC; and (iv) The correlation between SHs and SA in determining the risk of PC in different decades of life.
RESULTS: Vasectomy, STI, and marital status did not differ significantly between two cohorts. Controls reported premarital sex more commonly than cases (P < 0.001). Cases had the first intercourse at older age (P = 0.03) and had less SPM (P < 0.001). TT, FT, and ES were higher in controls (P < 0.001). In multivariate analysis, TT, calculated FT, SPM >4, and age at time of marriage <24 were protective against PC. The protective effect of high SA and SHs increased as patients' age increased.
CONCLUSIONS: High SA as well as TT and FT were protective against PC. Their protective role enhances by each decade of increasing age. The protective effect of high SA was independent from circulating levels of SHs.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21091879     DOI: 10.1111/j.1743-6109.2010.02115.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  6 in total

Review 1.  Testosterone Therapy Among Prostate Cancer Survivors.

Authors:  Taylor M Nguyen; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2016-07-27

2.  Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up.

Authors:  Jennifer R Rider; Kathryn M Wilson; Jennifer A Sinnott; Rachel S Kelly; Lorelei A Mucci; Edward L Giovannucci
Journal:  Eur Urol       Date:  2016-03-28       Impact factor: 20.096

Review 3.  The Role of Testosterone Therapy in the Setting of Prostate Cancer.

Authors:  Katherine M Rodriguez; Alexander W Pastuszak; Mohit Khera
Journal:  Curr Urol Rep       Date:  2018-06-30       Impact factor: 3.092

Review 4.  Testosterone therapy and prostate cancer.

Authors:  Alexander W Pastuszak; Katherine M Rodriguez; Taylor M Nguyen; Mohit Khera
Journal:  Transl Androl Urol       Date:  2016-12

5.  Polygamy, sexual behavior in a population under risk for prostate cancer diagnostic: an observational study from the Black Sea Region in Turkey.

Authors:  Abdullah Cirakoglu; Erdal Benli; Ahmet Yuce
Journal:  Int Braz J Urol       Date:  2018 Jul-Aug       Impact factor: 1.541

Review 6.  Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?

Authors:  David S Lopez; Shailesh Advani; Konstantinos K Tsilidis; Run Wang; Steven Canfield
Journal:  Transl Androl Urol       Date:  2017-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.